Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 5/2015

01-10-2015 | Conference commentary

ESCP–SFPC international workshop acquisition of pharmaceutical skills: simulation, serious games, innovative approaches 22–23 June 2015, Nice, France

Published in: International Journal of Clinical Pharmacy | Issue 5/2015

Login to get access

Excerpt

Background and objective: Good clinical practices (ICH-GCP 4.6) recommend that pharmacist” should ensure that the investigational product(s) are used only in accordance with the approved protocol”. However, there are no recommendations about how the pharmacist is supposed to do it. Dispensing investigational drugs is more complex than dispensing regular drugs. It requires a special training. The primary aim of the ACDC program is to ensure that pharmacy residents have obtained the designated training and competencies appropriate for dispensing and explaining the correct use investigational drugs to patients. …
Metadata
Title
ESCP–SFPC international workshop acquisition of pharmaceutical skills: simulation, serious games, innovative approaches 22–23 June 2015, Nice, France
Publication date
01-10-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0168-2

Other articles of this Issue 5/2015

International Journal of Clinical Pharmacy 5/2015 Go to the issue

Commentary

Recommendations to support deprescribing medications late in life

Erratum

Erratum to: Development of a consensus-base list of criteria for prescribing medication in a pediatric population

Research Article

Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial

Research Article

Critical appraisal of clinical practice guidelines in pediatric infectious diseases

Research Article

Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes

Research Article

Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits